Endemic carbapenem resistance associated with OXA-40 carbapenemase among Acinetobacter baumannii isolates from a hospital in northern Spain

被引：64

作者：

Lopez-Otsoa, F

Gallego, L

Towner, KJ ^{[1
]}

Tysall, L

Woodford, N

Livermore, DM

机构：

[1] Univ Nottingham Hosp, Queens Med Ctr, Publ Hlth Lab, Mol Diagnost & Typing Unit, Nottingham NG7 2UH, England

[2] Univ Basque Country, Fac Med & Odontol, Dept Microbiol Immunol & Parasitol, E-48080 Bilbao, Spain

[3] Cent Publ Hlth Lab, Antibiot Resistance Monitoring & Reference Lab, London NW9 5HT, England

来源：

JOURNAL OF CLINICAL MICROBIOLOGY | 2002年 / 40卷 / 12期

关键词：

D O I：

10.1128/JCM.40.12.4741-4743.2002

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Eighty-two carbapenem-resistant isolates of Acinetobacter baumannii from a single hospital in Bilbao were typed into two major clusters and several subclusters. Disk synergy tests and PCR indicated the production of a zinc-independent OXA-class carbapenemase. Sequencing identified this enzyme, OXA-40, as a variant of the OXA-24-OXA-25-OXA-26 cluster.

引用

页码：4741 / 4743

页数：3

共 25 条

[1] Characterization of OXA-25, OXA-26, and OXA-27, molecular class D β-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii
Afzal-Shah, M
Woodford, N
Livermore, DM
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (02) : 583 - 588
[2] Acinetobacter spp, as nosocomial pathogens: Microbiological, clinical, and epidemiological features
BergogneBerezin, E
Towner, KJ
[J]. CLINICAL MICROBIOLOGY REVIEWS, 1996, 9 (02) : 148 - +
[3] OXA-24, a novel class D β-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain
Bou, G
Oliver, A
Martínez-Beltran, J
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (06) : 1556 - 1561
[4] Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme:: High-level carbapenem resistance in A. baumannii is not due solely to the presence of β-lactamases
Bou, G
Cerveró, G
Domínguez, MA
Quereda, C
Martínez-Beltrán, J
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (09) : 3299 - 3305
[5] IMP-4, a novel metallo-β-lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and 1998
Chu, YW
Afzal-Shah, M
Houang, ETS
Palepou, MFI
Lyon, DJ
Woodford, N
Livermore, DM
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (03) : 710 - 714
[6] Imipenem resistance among Acinetobacter baumannii: Association with reduced expression of a 33-36 kDa outer membrane protein
Clark, RB
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (02) : 245 - 251
[7] Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii
Corbella, X
Montero, A
Pujol, M
Domínguez, MA
Ayats, J
Argerich, MJ
Garrigosa, F
Ariza, J
Gudiol, F
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (11) : 4086 - 4095
[8] Appearance of IMP-1 metallo-β-lactamase in Europe
Cornaglia, G
Riccio, ML
Mazzariol, A
Lauretti, L
Fontana, R
Rossolini, GM
[J]. LANCET, 1999, 353 (9156) : 899 - 900
[9] Sequence analysis of ARI-1, a novel OXA β-lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92
Donald, HM
Scaife, W
Amyes, SGB
Young, HK
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (01) : 196 - 199
[10] Acinetobacter species identification by using tRNA spacer fingerprinting
Ehrenstein, B
Bernards, AT
Dijkshoorn, L
GernerSmidt, P
Towner, KJ
Bouvet, PJM
Daschner, FD
Grundmann, H
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (10) : 2414 - 2420

← 1 2 3 →